Martin Shkreli's other drug pricing controversy
One of Martin Shkreli's companies announced plans to submit a treatment for a parasitic ailment known as Chagas disease for FDA approval next year, with plans to hike the price. The treatment can currently be obtained by doctors free through the CDC. Daisy Hernandez from Miami University and Bloomberg's Keri Geiger join to discuss.
Health care is a motivating issue in midterms, poll shows02:20
How healthcare has become a key midterm message for Democrats06:14
#GoodNewsRUHLES: Girl Scout teaches peers sign language00:49
2017 was deadliest flu season in four decades04:24
#GoodNewsRUHLES: Nike signs athlete with cerebral palsy00:49
Women in Trump country organize over health care04:32